Calmare Therapeutics Inc CTTC Stock Analysis
- OTCCE
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.00 unchanged at close Jul 14
Last close · Previous close $0.00
- 52-week change
- Price only
- Distributions
- Per share, last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$0.00down $0.00, 90.00%Past month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.00Jul 13
- Volume0.00Jul 14 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume11.00Last 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Jul 14 close. Total return includes reinvested dividends.Price change only, without dividends.
| Period | CTTC |
|---|---|
| Short term | |
| 1M | CTTC: down 90.0% |
| 3M | CTTC: down 99.0% |
| YTD | CTTC: down 99.5% |
| 1Y | CTTC: down 100.0% |
| Long term | |
| 3Y | CTTC: down 100.0% −97.7% a year |
| 5Y | CTTC: down 100.0% −90.4% a year |
| 10Y | CTTC: down 100.0% −70.2% a year |
$10,000 invested in CTTC 10 years ago (Jul 12, 2013) would be worth about $0 at the close on , with dividends reinvested.
| Period | CTTC |
|---|---|
| Short term | |
| 1M | CTTC: down 90.0% |
| 3M | CTTC: down 99.0% |
| YTD | CTTC: down 99.5% |
| 1Y | CTTC: down 100.0% |
| Long term | |
| 3Y | CTTC: down 100.0% −97.7% a year |
| 5Y | CTTC: down 100.0% −90.4% a year |
| 10Y | CTTC: down 100.0% −70.2% a year |
$10,000 invested in CTTC 10 years ago (Jul 12, 2013) would be worth about $0 at the close on , not counting dividends.
All-time high
$48.50
Closing high on . Now 100.0% below that record.
Split-adjusted daily closes since Oct 1, 2007.
Stock splits
CTTC hasn’t split since its price history begins in 2007.
Valuation
About Calmare Therapeutics Inc
Competitive Technologies, Inc. (CTTC) provides distribution, patent and technology transfer, sales and licensing services focusing on the needs of its customers. CTTC develops relationships with universities, companies, inventors and patent or intellectual property holders to obtain the rights or a license to their intellectual property (technologies) or to their product. The Company also develops relationships with those who have a need or uses for technologies or products. During the year ended December 31, 2011, the Company earned revenue in two ways: retained royalties from licensing its clients' and its own technologies to its customer licensees, and sales of finished products. CTTC is the obligor, responsible for delivering devices, as well as for training its customers to use the device. The Company deals directly with customers, setting pricing and providing training.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Connecticut, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- OTCCE
- Asset type
- Common stock
- Price history since
CTTC news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
CTTC stock FAQ
What is CTTC stock’s price today?
Calmare Therapeutics (CTTC) traded at $0.00 at the close on , unchanged from the previous close of $0.00.
If you invested $1,000 in CTTC 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in CTTC on would be worth about $0 at the close on , a total return of −100.0%. The same $1,000 would be worth $0 if invested five years ago and $0 if invested one year ago. Past performance doesn’t predict future returns.
Does CTTC pay a dividend?
Calmare Therapeutics hasn’t paid a dividend in the last twelve months.
What is CTTC’s all-time high?
CTTC’s highest closing price was $48.50 on , adjusted for stock splits. At $0.00 at the close on , it is 100.0% below that record.
Has CTTC stock ever split?
No. CTTC hasn’t split since its price history begins in 2007.
How has CTTC stock performed?
Including dividends and measured to the close on , CTTC has returned −99.5% so far this year and −100.0% over the past year, and −100.0% over five years (−90.4% a year). Past performance doesn’t predict future returns.
What sector and industry is Calmare Therapeutics in?
Calmare Therapeutics is in the Healthcare sector and the Medical Devices industry, and is headquartered in Connecticut, USA.
What exchange does CTTC trade on?
Calmare Therapeutics trades on the OTCCE under the ticker symbol CTTC. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.